Safety of FLT3 inhibitors in patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Safety of FLT3 inhibitors in patients with acute myeloid leukemia

Published:2021-08-30 Issue:9 Volume:14 Page:851-865
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Cerchione Claudio¹^ORCID,Peleteiro Raíndo Andrés²³,Mosquera Orgueira Adrián²³,Mosquera Torre Alicia²³,Bao Pérez Laura²³,Marconi Giovanni¹,Isidori Alessandro⁴,Pérez Encinas Manuel Mateo²³⁵^ORCID,Martinelli Giovanni¹

Affiliation:

1. Hematology Unit, IRCCS Istituto Scientifico Romagnolo per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

2. Health Research Institute of Santiago De Compostela (Idis), Santiago De Compostela, Spain;

3. Division of Hematology, Complejo Hospitalario Universitario De Santiago (Chus), Santiago De Compostela, Spain

4. Hematology and Stem Cell Transplant Center, Aormn Hospital, Pesaro, Italy

5. University of Santiago De Compostela, Santiago De Compostela, Spain

Funder

not funded

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1969911

Reference94 articles.

1. Acquired copy number alterations in adult acute myeloid leukemia genomes

2. Genomic Classification and Prognosis in Acute Myeloid Leukemia

3. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

4. Targeting FLT3 mutations in AML: review of current knowledge and evidence

5. Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of midostaurin in plasma and serum by stable isotope dilution liquid chromatography‐tandem mass spectrometry: Application to a cohort of patients with acute myeloid leukemia;European Journal of Haematology;2024-01-31

2. Cardiotoxicity in Pediatric AML;Pediatric Oncology;2024

3. Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia;European Journal of Medicinal Chemistry;2023-12

4. FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review;Critical Reviews in Oncology/Hematology;2023-11

5. Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-08